SA Health- 10th October 2022

SA Health- 10th October 2022

10 Oct 2022

Three of South Australia’s brightest medical minds will share their latest cutting-edge research as part of this year’s Royal Adelaide Hospital (RAH) research showcase.

RAHsearch is an annual event held by the Central Adelaide Local Health Network (CALHN), which provides a unique opportunity for South Australians to learn first-hand about the transformative and life-impacting research taking place in South Australia on some of the most common diseases and conditions.

The presentations being held on Monday 17 October will highlight a variety of research projects being conducted at CALHN, with a focus on the fundamental link between research and better health outcomes for the community.

The public are now able to sign up to be part of RAHsearch where they will hear about what’s new in the areas of bowel disease, diabetes, and leukemia. Topics include how faecal transplants and diet can treat bowel disease, a new hope for those living with type 1 diabetes and tailoring treatment for patients with Chronic Myeloid Leukaemia.

The Queen Elizabeth Hospital (TQEH) Head of Inflammatory Bowel Diseases, Associate Professor Robert Bryant will be presenting his research into how diet modifications and faecal transplants are helping patients with inflammatory bowel diseases (IBD).

The research conducted at the RAH and TQEH examines how introducing good bacteria or ‘super poo’ into the gut can create changes in the lining of the colon, providing important and potentially lifesaving relief.

A world-first human trial of a ground-breaking new islet transplantation method using an artificial skin graft, which has the potential to be the next step in finding a cure for type 1 diabetes, will also be presented on the day by RAH Director of Kidney and Islet Transplantation, Professor Toby Coates.

The community will also get to hear from RAH Haematology Unit Consultant Haematologist, Dr Naranie Shanmuganathan, who will showcase her research into identifying the factors in Chronic Myeloid Leukemia that can predict how patients may respond to therapy and eventually be able to cease medication.

During each of the hour-long sessions, a patient for each research study will be part of the presentation to share their first-hand experiences and treatment, which will be followed by a panel discussion and an opportunity for the community to ask questions.

RAHsearch is taking place at the RAH Level 8 Lecture Theatre and will also be live streamed via Facebook.